Header cover image
  • Investing Ideas
  • German Pharmaceuticals & Biotech Large Cap High Growth Potential

German Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

Bayer

Market Cap: €39.5b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

BAYN

€40.21

7D

1.5%

1Y

62.4%